Antidiabetic and immunoprophylactic effects of camel milk filtrate and bitter gourd (Momordica charantia) juice against alloxan-induced oxidative stress and diabetes in rats

International Journal of Pharmacology

Volumn 14, Issue 3, 2018, Pages 397-406

  Abdel Salam, Ahmed M ^a   Al Damegh, Mona A ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Bitter gourd; Camel milk filtrate; Diabetes; Membrane technology; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA 2 GLOBULIN; ASPARTATE AMINOTRANSFERASE; BETA GLOBULIN; CREATININE; IMMUNOGLOBULIN; OROSOMUCOID; TRIACYLGLYCEROL;

AGAR GEL ELECTROPHORESIS; ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; CAMEL MILK; CONTROLLED STUDY; MALE; MOMORDICA CHARANTIA; NONHUMAN; OXIDATIVE STRESS; PROPHYLAXIS; RAT;

EID: 85044955144     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2018.397.406     Document Type: Article

References (40)

1. Kumar, P.J. and M. Clark, 2002. Textbook of Clinical Medicine. Saunders Publ., London, UK., pp: 1099-1121.
2. Elangovan, V., E. Shohami, I. Gati and R. Kohen, 2000. Increased hepatic lipid soluble antioxidant capacity as compared to other organs of streptozotocin-induced diabetic rats: A cyclic voltammetry study. Free Radical Res., 32: 125-134.
3. Sato, Y., N. Hotta, N. Sakamoto, S. Matsuoks, N. Ohishi and K. Yagi, 1979. Lipid peroxide level in plasma of diabetic patients. Biochem. Med., 21: 104-107.
4. Hunt, J.V., C.C. Smith and S.P. Wolff, 1990. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes, 39: 1420-1424.
5. Kenzhebulat, S., B. Ermuhan and A. Tleuov, 2000. Composition of camel milk and its use in the treatment of infectious diseases in human. Proceedings of the 2nd Camelid Conference on Agroeconomics of Camelid Farming, September 8-12, 2000, Sheffield, England, pp: 101.
6. Mal, G., D.S. Sena, V.K. Jain and M.S. Sahani, 2006. Therapeutic value of camel milk as a nutritional supplement for Multiple Drug Resistant (MDR) tuberculosis patients. Isr. J. Vet. Med., 61: 88-91.
7. Magjeed, N.A.A., 2005. Corrective effect of milk camel on some cancer biomarkers in blood of rats intoxicated with aflatoxin B1. J. Saudi Chem. Soc., 9: 253-264.
8. Shabo, Y., R. Barzel, M. Margoulis and R. Yagil, 2005. Camel milk for food allergies in children. Isr. Med. Assoc. J., 7: 796-798.
9. Agrawal, R.P., D.K. Kochar, M.S. Sahani, F.C. Tuteja and S.K. Ghorui, 2004. Hypoglycemic activity of camel milk in streptozotocin induced diabetic rats. Int. J. Diabetes Dev. Countries, 24: 47-49.
10. Agarwal, M. and R. Kamal, 2004. In vitro clonal propagation of Momordica charantia L. Indian J. Biotechnol., 3: 426-430.
11. Karray, N., C. Lopez, M. Ollivon and H. Attia, 2005. La matiere grasse du lait de dromadaire: Composition, microstructure et polymorphisme Une revue. OCL Oleagineux Corps Gras Lipides, 12: 441-448.
12. Konuspayeva, G., E. Lemarie, B. Faye, G. Loiseau and D. Montet, 2008. Fatty acid and cholesterol composition of camel's (Camelus bactrianus, Camelus dromedarius and hybrids) milk in Kazakhstan. Dairy Sci. Technol., 88: 327-340.
13. El-Agamy, E.I., 2006. Camel Milk. In: Handbook of Milk of Non-Bovine Mammals, Park, Y.W. and G.F.W. Haenlein (Eds.). Blackwell Publishing, Oxford, UK., ISBN-13: 9780470999721, pp: 297-344.
14. Konuspayeva, G., B. Faye and G. Loiseau, 2009. The composition of camel milk: A meta-analysis of the literature data. J. Food Compos. Anal., 22: 95-101.
15. Pouliot, Y., 2008. Membrane processes in dairy technology-from a simple idea to worldwide panacea. Int. Dairy J., 18: 735-740.
16. Taylor, L., 2002. Technical Data Report for Bitter Melon (Momordica charantia), Herbal Secrets of the Rainforest. 2nd Edn., Sage Press Inc., Los Angeles, London.
17. Jeevathayaparan, S., K.H. Tennekoon and E.H. Karunanayake, 1995. A comparative study of the oral hypoglycaemic effect of Momordica charantia fruit juice and tolbutamine in streptozotocin induced graded severity diabetes in rat. Int. J. Diabetes, 3: 99-108.
18. Kirtikar, K.R. and B.D. Basu, 1987. Indian Medicinal Plants. Bishen Singh Mahendra Pal Singh, Dehra Dun, India.
19. AOAC., 1990. Official Method of Analysis. 15th Edn., Association of Official Analytical Chemists, Washington, DC., USA.
20. Reeves, P.G., F.H. Nielsen and G.C. Fahey Jr., 1993. AIN-93 purified diets for laboratory rodents: Final report of the American institute of nutrition Ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr., 123: 1939-1951.
21. Wawersik, J., 1991. History of anesthesia in Germany. J. Clin. Anesth., 3: 235-244.
22. Werner, L.L. and D.R. Reavill, 1999. The diagnostic utility of serum protein electrophoresis. Vet. Clin. North Am.: Exotic Anim. Pract., 2: 651-662.
23. Brodrick, J.M., P.S. Colloby and E.F. Legg, 1987. Comparison of two new ward-based glucose meters. Pract. Diabetes Int., 4: 170-172.
24. Reitman, S. and S. Frankel, 1957. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol., 28: 56-63.
25. Tietz, N.W., 1970. Fundamentals of Clinical Chemistry. 1st Edn., W.B. Sounders, Philadelphia.
26. Bousnes, R.W. and A.A. Taussky, 1945. On the colorimetric determination of creatinine by the Jaffe reaction. J. Biol. Chem., 158: 581-591.
27. Stein, E.A and G.L. Myers, 1995. National cholesterol education program recommendations for triglyceride measurement: Executive summary. The national cholesterol education program working group on lipoprotein measurement. Clin. Chem., 41: 1421-1426.
28. Miller, J.C. and J.N. Miller, 1992. Statistics for Analytical Chemistry. 2nd Edn., Ellis Horweed, New York, London, Tokyo.
29. FAOSTAT., 2013. Camel milk (whole, fresh) production (tonnes). FAO Statistics Division, Rome, Italy. http://faostat.fao.org/site/569/default.aspx#ancor
30. Bottomley, R.C., 1991. Process for obtaining concentrates having a high α-lactalbumin content from whey. U.S. Patent 5,008,376, April 16, 1991. https://www.google.com/patents/US5008376
31. Myers, G.L., W.G. Miller, J. Coresh, J. Fleming, N. Greenberg and T. Greene, 2006. Recommendations for improving serum creatinine measurement: A report from the laboratory working group of the national kidney disease education program. Clin. Chem., 52: 5-18.
32. Prochazkova, J., I. Sterzl, H. Kucerova, J. Bartova and V.D. Stejskal, 2004. The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuroendocrinol. Lett., 25: 211-218.
33. Hudson, C., L. Cao, J. Kasten-Jolly, J. Kirkwood and D. Lawrence, 2003. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J. Toxicol. Environ. Health Part A, 66: 895-918.
34. Agrawal, R.P., S. Saran, P. Sharma, R.P. Gupta, D.K. Kochar and M.S. Sahani, 2007. Effect of camel milk on residual β-cell function in recent onset type 1 diabetes. Diabetes Res. Clin. Pract., 77: 494-495.
35. Mullaicharam, A.R., 2014. A review on medicinal properties of camel milk. World J. Pharm. Sci., 2: 237-242.
36. Malik, A., A. Al-Senaidy, E. Skrzypczak-Jankun and J. Jankun, 2012. A study of the anti-diabetic agents of camel milk. Int. J. Mol. Med., 30: 585-592.
37. Beg, O.U., H. von Bahr-Lindstrom, Z.H. Zaidi and H. Jornvall, 1986. Characterization of a camel milk protein rich in proline identifies a new β-casein fragment. Regul. Pept., 15: 55-61.
38. Hamers-Casterman, C., T. Atarhouch, S. Muyldermans, G. Robinson and C. Hammers et al., 1993. Naturally occurring antibodies devoid of light chains. Nature, 363: 446-448.
39. Beloin, N., M. Gbeassor, K. Akpagana, J. Hudson, K. de Soussa, K. Koumaglo and J.T. Arnason, 2005. Ethnomedicinal uses of Momordica charantia (Cucurbitaceae) in Togo and relation to its phytochemistry and biological activity. J. Ethnopharmacol., 96: 49-55.
40. Zafar, R. and Neerja, 1991. Momordica charantia-a review. Hamdard Medicus, 34: 49-61.